Platform Technology Partners’s Elevance Health ELV Stock Holding History

Platform Technology Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$297K	Buy	767 +52	+7%	+$19.3K	0.05%	259
2026 Q1	$209K	Buy	+715	New	+$235K	0.04%	310
2025 Q3	–	Sell	-526	Closed	-$205K	–	263
2025 Q2	$205K	Hold	526	–	–	0.05%	240
2025 Q1	$229K	Sell	526 -17	-3%	-$6.82K	0.07%	205
2024 Q4	$200K	Sell	543 -200	-27%	-$83.7K	0.06%	209
2024 Q3	$386K	Sell	743 -5	-0.7%	-$2.67K	0.12%	152
2024 Q2	$405K	Buy	+748	New	+$395K	0.14%	134
2023 Q4	$378K	Hold	748	–	–	0.15%	138
2023 Q3	$326K	Buy	+748	New	+$339K	0.15%	137

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Platform Technology Partners's ELV Position: Q2 2026 in Review

Platform Technology Partners increased its Elevance Health (ELV) stake by 7.3% in Q2 2026, buying an estimated $19.3K and bringing the position to 767 shares worth $297K. The position accounts for 0.05% of the portfolio, ranked #259.

Platform Technology Partners first reported a position in ELV in Q3 2023 and has held it in 9 quarters since. The position peaked at $405K in Q2 2024. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Platform Technology Partners held 767 shares of Elevance Health worth $297K as of Q2 2026.
Platform Technology Partners bought 52 Elevance Health shares in Q2 2026, an estimated $19.3K.
Elevance Health made up 0.05% of Platform Technology Partners's portfolio in Q2 2026, its #259 holding.
Platform Technology Partners first reported a position in Elevance Health in Q3 2023 and has held it in 9 quarters since.
Platform Technology Partners's Elevance Health position peaked at $405K in Q2 2024.
1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.